Titles and Roles
- Assistant Professor, Department of Hematology and Medical Oncology
- Emory University School of Medicine
- Interim Medical Director, Early Phase I Developmental Therapeutics
- Winship Cancer Institute of Emory University
- Medical Oncologist
- Breast Cancer
- Phase I Clinical Trials Unit
- Research Program
- Discovery and Developmental Therapeutics
Manali Bhave, MD, is Assistant Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Board certified in medical oncology and internal medicine, Dr. Bhave specializes in breast oncology. She joined the Glenn Family Breast Center at Winship Cancer Institute in 2018. Prior to her appointment at Winship, she was a clinical instructor at Northwestern University in Chicago.
Dr. Bhave has a special interest in developing new strategies for the treatment of patients with breast cancer. As a member of the breast cancer working group and as interim medical director of the Phase I Clinical Trials Unit at Winship Cancer Institute of Emory University, she is actively involved in clinical trials and early drug development. Her goal is to provide compassionate, personalized and state-of-the-art care for her patients through the use of both standard of care therapies and clinical trials.
Dr. Bhave is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute of Emory University. She holds professional memberships with American Society of Clinical Oncology and American Society of Hematology. She is also a member of the Hoosier Cancer Research Network.
Dr. Bhave earned her medical degree from Northwestern University Feinberg School of Medicine in Chicago, Illinois. She completed her residency in internal medicine and women’s health also at Northwestern University. She then completed her fellowship in both medical oncology and hematology at the University of Michigan in Ann Arbor where she served as Chief Fellow in her final year.
Dr. Bhave's research focus is in the development of novel therapies including immunotherapy and multimodality strategies for the treatment of breast cancer. She also has an interest in fertility care during breast cancer therapy and improving the quality of life for her patients. She serves as the principal investigator for multiple therapeutic trials for patients with breast cancer and other advanced malignancies at Winship.
Below is a listing of current federal grants for the above principal investigator.
Dr. Bhave has presented her research in breast cancer at national meetings and has published her work in peer-reviewed journals.
Publications Publication Date
Dr. Bhave has received multiple teaching awards during her time at Northwestern University and at the University of Michigan. She also received the Mark Roth Award from the University of Michigan in 2017 for both clinical and research excellence. She was recently awarded a generous grant through the V Foundation to improve patient enrollment in breast cancer immunotherapy clinical trials.